Epidemiology of HIV-1 infection in opiate users in Northern Thailand.

DonateNow
Print this article

Epidemiology of HIV-1 infection in opiate users in Northern Thailand.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jan 1;17(1):73-8. Unique Identifier : AIDSLINE MED/98097262
Celentano DD; Jittiwutikorn J; Hodge MJ; Beyrer C; Nelson KE; The Johns Hopkins University, Baltimore, Maryland 21205, USA.


Abstract: Characterizing the epidemiology of HIV-1 infection in Northern Thai opiate users is important in developing control strategies in this ethnically diverse and culturally distinct region. A cross-sectional survey of drug users first admitted between 1993 and 1995 at the Northern Drug Dependence Treatment Center, Mae Rim, Thailand, was conducted. Patients (n = 4197) were interviewed at intake about their history of drug use when they provided serum specimens for HIV-1 antibody testing. The HIV-1 prevalence was 18.6%, with men having a fourfold higher prevalence than women. Wide diversity in HIV-1 prevalence was seen by ethnicity; the HIV-1 prevalence among Thai lowlanders was four times greater than that among ethnic minorities (hill tribes). Differences in HIV-1 prevalence were the result of differences in opiate use; hill tribes frequently smoked or ingested opium, whereas Thai lowlanders injected heroin. The high HIV-1 prevalence suggests that preventive interventions for risk reduction are urgently needed in these populations. Education about the risks of injection drug use (IDU) as well as information concerning needle disinfection and expansion of drug treatment are required to reduce the risk of HIV-1 transmission associated with sharing injection equipment. Further, increasing sources of sterile needles should be considered for active users, especially for those in more remote settings.
Keywords: *HIV Seropositivity/COMPLICATIONS *HIV Seropositivity/EPIDEMIOLOGY *HIV-1 *Opioid-Related Disorders/COMPLICATIONSKWDhivseropositivity/complicationsKWDhivseropositivity/epidemiologyKWDhiv-1KWDopioid-relateddisorders/complications
980430
M9841796

ÆGIS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGiS, or the party credited as the provider of the content.